Venous Thrombosis Risk Analysis Panel Test sale cost 1290 AED
Factor V Leiden Mutation Analysis Test sale cost 1290 AED Factor V Leiden Mutation Analysis Test 1,430 د.إ Original price was: 1,430 د.إ.1,290 د.إCurrent price is: 1,290 د.إ.
LDL Subfractions Test sale cost 1000 AED LDL Subfractions Test 1,300 د.إ Original price was: 1,300 د.إ.1,000 د.إCurrent price is: 1,000 د.إ.
Sale!

Venous Thrombosis Risk Analysis Panel Test

Original price was: 1,430 د.إ.Current price is: 1,290 د.إ.

-10%

The Venous Thrombosis Risk Analysis Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to assess an individual’s risk of developing venous thrombosis. Venous thrombosis, a condition characterized by the formation of blood clots within the veins, can lead to serious complications such as pulmonary embolism if left undetected or untreated. This test analyzes specific genetic markers and other factors that may contribute to the likelihood of clot formation, providing valuable insights into an individual’s predisposition to this condition.

Priced at 1290 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of the results. By evaluating the genetic and molecular components associated with venous thrombosis, the test aids in the early detection and management of the risk, facilitating personalized preventive strategies and interventions. It is an essential tool for individuals with a family history of venous thrombosis or those who exhibit potential risk factors, aiming to enhance healthcare outcomes through precision medicine.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Venous Thrombosis Risk Analysis Panel Test

Test Cost: AED 1290.0

Symptoms, Diagnosis, and Referring Details:

  • Test Name: Venous Thrombosis Risk Analysis Panel Test
  • Test Components: Factor V Leiden Mutation, Prothrombin Gene Mutation, MTHFR Gene Mutation
  • Price: 1290.0 AED
  • Sample Condition: 5mL (3mL min.) whole blood in 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE.
  • Report Delivery: Sample Mon/Thu by 11am; Report Wed/Sat
  • Method: Real Time PCR
  • Test Type: Thromboembolic Disorders
  • Doctor: Hematologist
  • Test Department: Molecular Diagnostics
  • Pre Test Information: No special preparation required

Test Details

The Venous Thrombosis Risk Analysis Panel Test is a diagnostic tool used to assess an individual’s risk of developing venous thrombosis, which is the formation of blood clots in the veins. This test is typically ordered for patients who have a personal or family history of venous thrombosis or have risk factors such as obesity, smoking, or hormonal contraceptive use.

The panel test usually includes several blood tests that evaluate different aspects of the clotting process. These tests may include:

  1. D-dimer test: This test measures the level of D-dimer, a protein fragment that is elevated when blood clots are being broken down. A high level of D-dimer may indicate the presence of a blood clot.
  2. Antithrombin assay: This test measures the level of antithrombin, a protein that helps regulate blood clotting. Low levels of antithrombin can increase the risk of clot formation.
  3. Protein C assay: This test measures the level of protein C, a protein that helps regulate blood clotting. Low levels of protein C can increase the risk of clot formation.
  4. Protein S assay: This test measures the level of protein S, a protein that works with protein C to regulate blood clotting. Low levels of protein S can increase the risk of clot formation.
  5. Factor V Leiden mutation test: This test checks for a specific genetic mutation called factor V Leiden, which increases the risk of blood clotting.
  6. Prothrombin gene mutation test: This test checks for a specific genetic mutation in the prothrombin gene, which can increase the risk of blood clotting.

By analyzing the results of these tests, healthcare providers can determine an individual’s risk of developing venous thrombosis and make appropriate recommendations for prevention or treatment. This may include lifestyle modifications, medication, or further testing.

Test Name VENOUS THROMBOSIS RISK ANALYSIS PANEL Test
Components *FactorVLeidenMutation*ProthrombinGene Mutation*MTHFRGeneMutation
Price 1290.0 AED
Sample Condition 5mL(3mLmin.)wholebloodin2 LavenderTop(EDTA)tubes.Ship refrigerated. DO NOT FREEZE.
Report Delivery SampleMon / Thu by 11am;Report Wed/Sat
Method Real Time PCR
Test type Thromboembolic disorders
Doctor Hematologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information No special preparation required
Test Details

The Venous Thrombosis Risk Analysis Panel Test is a diagnostic tool used to assess an individual’s risk of developing venous thrombosis, which is the formation of blood clots in the veins. This test is typically ordered for patients who have a personal or family history of venous thrombosis or have risk factors such as obesity, smoking, or hormonal contraceptive use.

The panel test usually includes several blood tests that evaluate different aspects of the clotting process. These tests may include:

1. D-dimer test: This test measures the level of D-dimer, a protein fragment that is elevated when blood clots are being broken down. A high level of D-dimer may indicate the presence of a blood clot.

2. Antithrombin assay: This test measures the level of antithrombin, a protein that helps regulate blood clotting. Low levels of antithrombin can increase the risk of clot formation.

3. Protein C assay: This test measures the level of protein C, a protein that helps regulate blood clotting. Low levels of protein C can increase the risk of clot formation.

4. Protein S assay: This test measures the level of protein S, a protein that works with protein C to regulate blood clotting. Low levels of protein S can increase the risk of clot formation.

5. Factor V Leiden mutation test: This test checks for a specific genetic mutation called factor V Leiden, which increases the risk of blood clotting.

6. Prothrombin gene mutation test: This test checks for a specific genetic mutation in the prothrombin gene, which can increase the risk of blood clotting.

By analyzing the results of these tests, healthcare providers can determine an individual’s risk of developing venous thrombosis and make appropriate recommendations for prevention or treatment. This may include lifestyle modifications, medication, or further testing.

SKU: TEST-5519 Category:

Related products